Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca announces that Tagrisso granted breakthrough therapy designation (BTD) by US FDA

pharmaasiaOctober 17, 2017

Tag: AstraZeneca , BTD , FDA

PharmaSources Customer Service